Management Board of NESTMEDIC S.A. based in Warsaw (hereinafter referred to as the “Company”, “Issuer”), encloses the separate and consolidated quarterly report for the second quarter of 2022 as attached.
Legal basis:
§ 5 clause 1 point 1 of Annex 3 to the Regulations of the Alternative Trading System “Current and Periodic Information provided in the Alternative Trading System on the NewConnect market”
Nestmedic S.A. consolidated and separate periodical report for the second quarter of 2022/a>
